Log in
Enquire now
‌

US Patent 9694025 Cyclic boronic acid ester derivatives and therapeutic uses thereof

Patent 9694025 was granted and assigned to Rempex Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Rempex Pharmaceuticals
Rempex Pharmaceuticals
Current Assignee
Rempex Pharmaceuticals
Rempex Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9694025
Date of Patent
July 4, 2017
Patent Application Number
15015002
Date Filed
February 3, 2016
Patent Citations Received
‌
US Patent 12016868 Boronic acid derivatives and therapeutic uses thereof
0
‌
US Patent 11999759 Boronic acid derivatives and therapeutic uses thereof
0
Patent Primary Examiner
‌
Golam M. M. Shameem
Patent abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronic acid ester derivatives and their use as therapeutic agents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9694025 Cyclic boronic acid ester derivatives and therapeutic uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.